{"id":713,"date":"2023-10-31T00:04:27","date_gmt":"2023-10-31T00:04:27","guid":{"rendered":"https:\/\/economicherald.net\/?p=713"},"modified":"2023-10-31T00:04:27","modified_gmt":"2023-10-31T00:04:27","slug":"top-10-at-11ish-chimeric-therapeutics-soars-58pc-on-us-fda-clearance","status":"publish","type":"post","link":"https:\/\/economicherald.net\/?p=713","title":{"rendered":"Top 10 at 11ish: Chimeric Therapeutics soars 58pc on US FDA clearance"},"content":{"rendered":"

Good morning, and welcome to Stockhead\u2019s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.<\/p>\n

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading \u2013\u00a0for better or worse.<\/p>\n

\u00a0<\/p>\n

WINNERS<\/h2>\n

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).<\/p>\n

<\/div>\n
Code Company Price % Volume Market Cap CHM Chimeric Therapeutic 0.041 58% 12,929,127 $13,889,277 NNG Nexion Group 0.019 46% 568,874 $2,630,002 FZR Fitzroy River Corp 0.15 36% 15,000 $11,874,968 ENT Enterprise Metals 0.004 33% 1,277,948 $2,398,413 TOY Toys R Us 0.014 27% 3,690,875 $10,807,099 KPO Kalina Power Limited 0.005 25% 101,029 $6,060,783 EDE Eden Inv Ltd 0.003 20% 101,374 $8,409,092 GHY Gold Hydrogen 0.31 19% 182,626 $14,799,986 KRR King River Resources 0.02 18% 2,654,644 $26,409,924 PGM Platina Resources 0.027 17% 27,880 $14,333,148 <\/div>\n

WordPress Tables Plugin<\/a><\/p>\n

Chimeric Therapeutics (ASX:CHM)<\/strong><\/a> is up 58% in opening trade after the\u00a0 US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of CHM 2101, the company\u2019s first in class CDH17 CAR T cell therapy for gastrointestinal cancers.<\/p>\n

CHM plans to investigate CHM 2101 in a multi-centre, open label Phase 1A\/B clinical trial for patients with advanced colorectal cancer, gastric cancer and neuroendocrine tumours.<\/p>\n

Gold Hydrogen (ASX:GHY)<\/a> is up after announcing significant concentrations of hydrogen and helium have found at the Ramsay 1 well, confirming historic measurement and demonstrating an active hydrogen system in the Ramsay Project area, on South Australia\u2019s Yorke Pennisula.<\/p>\n

Testing and laboratory results measured air-corrected hydrogen at 73.3% at 240m below ground level, consistent with the 76% air-corrected concentration of hydrogen reported in the Ramsay Oil Bore 1 in 1931.<\/p>\n

\u00a0<\/p>\n

LOSERS<\/h2>\n

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).<\/p>\n

<\/div>\n
Code Company Price % Volume Market Cap MTH Mithril Resources 0.001 -33% 33,334 $5,053,207 RAD Radiopharm 0.08 -20% 590,095 $23,931,304 SFG Seafarms Group 0.004 -20% 9,388 $24,182,996 MDI Middle Island Resources 0.019 -17% 786,972 $3,235,139 CRB Carbine Resources 0.005 -17% 988,294 $3,310,427 ASH Ashley Services Grp 0.44 -15% 138,459 $74,147,591 BSE Base Res Limited 0.12 -14% 1,713,970 $164,921,659 IEC Intra Energy Corp 0.0035 -13% 7,094 $6,643,126 MKG Mako Gold 0.014 -13% 700,416 $9,216,131 XPN Xpon Technologies 0.035 -13% 500 $6,341,101 <\/div>\n

WordPress Tables Plugin<\/a><\/p>\n

Gold explorer Middle Island Resources (ASX:MDI)<\/strong><\/a> has fallen this morning after announcing a capital raise. MDI says it seeks to raise a minimum of $1 million and up to $1, 054,937, before costs via a pro rata renounceable rights offer.<\/p>\n

<\/span><\/p>\n

The post Top 10 at 11ish: Chimeric Therapeutics soars 58pc on US FDA clearance<\/a> appeared first on Stockhead<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"

Good morning, and welcome to Stockhead\u2019s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live [more…]<\/a><\/p>\n","protected":false},"author":0,"featured_media":714,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-713","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance"],"yoast_head":"\nTop 10 at 11ish: Chimeric Therapeutics soars 58pc on US FDA clearance - Economic Herald<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/economicherald.net\/?p=713\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Top 10 at 11ish: Chimeric Therapeutics soars 58pc on US FDA clearance - Economic Herald\" \/>\n<meta property=\"og:description\" content=\"Good morning, and welcome to Stockhead\u2019s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live [more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/economicherald.net\/?p=713\" \/>\n<meta property=\"og:site_name\" content=\"Economic Herald\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-31T00:04:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/10-5-ufGniP.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2097\" \/>\n\t<meta property=\"og:image:height\" content=\"1180\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=713#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=713\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Top 10 at 11ish: Chimeric Therapeutics soars 58pc on US FDA clearance\",\"datePublished\":\"2023-10-31T00:04:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=713\"},\"wordCount\":394,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=713#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/10-5-ufGniP.jpeg\",\"articleSection\":[\"Finance\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/economicherald.net\\\/?p=713#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=713\",\"url\":\"https:\\\/\\\/economicherald.net\\\/?p=713\",\"name\":\"Top 10 at 11ish: Chimeric Therapeutics soars 58pc on US FDA clearance - Economic Herald\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=713#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=713#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/10-5-ufGniP.jpeg\",\"datePublished\":\"2023-10-31T00:04:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=713#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/economicherald.net\\\/?p=713\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=713#primaryimage\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/10-5-ufGniP.jpeg\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/10-5-ufGniP.jpeg\",\"width\":2097,\"height\":1180},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=713#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/economicherald.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Top 10 at 11ish: Chimeric Therapeutics soars 58pc on US FDA clearance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"name\":\"Economic Herald\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/economicherald.net\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\",\"name\":\"Economic Herald\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"width\":850,\"height\":760,\"caption\":\"Economic Herald\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Top 10 at 11ish: Chimeric Therapeutics soars 58pc on US FDA clearance - Economic Herald","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/economicherald.net\/?p=713","og_locale":"en_US","og_type":"article","og_title":"Top 10 at 11ish: Chimeric Therapeutics soars 58pc on US FDA clearance - Economic Herald","og_description":"Good morning, and welcome to Stockhead\u2019s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live [more...]","og_url":"https:\/\/economicherald.net\/?p=713","og_site_name":"Economic Herald","article_published_time":"2023-10-31T00:04:27+00:00","og_image":[{"width":2097,"height":1180,"url":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/10-5-ufGniP.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/economicherald.net\/?p=713#article","isPartOf":{"@id":"https:\/\/economicherald.net\/?p=713"},"author":{"name":"","@id":""},"headline":"Top 10 at 11ish: Chimeric Therapeutics soars 58pc on US FDA clearance","datePublished":"2023-10-31T00:04:27+00:00","mainEntityOfPage":{"@id":"https:\/\/economicherald.net\/?p=713"},"wordCount":394,"commentCount":0,"publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"image":{"@id":"https:\/\/economicherald.net\/?p=713#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/10-5-ufGniP.jpeg","articleSection":["Finance"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/economicherald.net\/?p=713#respond"]}]},{"@type":"WebPage","@id":"https:\/\/economicherald.net\/?p=713","url":"https:\/\/economicherald.net\/?p=713","name":"Top 10 at 11ish: Chimeric Therapeutics soars 58pc on US FDA clearance - Economic Herald","isPartOf":{"@id":"https:\/\/economicherald.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/economicherald.net\/?p=713#primaryimage"},"image":{"@id":"https:\/\/economicherald.net\/?p=713#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/10-5-ufGniP.jpeg","datePublished":"2023-10-31T00:04:27+00:00","breadcrumb":{"@id":"https:\/\/economicherald.net\/?p=713#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/economicherald.net\/?p=713"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/?p=713#primaryimage","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/10-5-ufGniP.jpeg","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/10-5-ufGniP.jpeg","width":2097,"height":1180},{"@type":"BreadcrumbList","@id":"https:\/\/economicherald.net\/?p=713#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/economicherald.net\/"},{"@type":"ListItem","position":2,"name":"Top 10 at 11ish: Chimeric Therapeutics soars 58pc on US FDA clearance"}]},{"@type":"WebSite","@id":"https:\/\/economicherald.net\/#website","url":"https:\/\/economicherald.net\/","name":"Economic Herald","description":"","publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/economicherald.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/economicherald.net\/#organization","name":"Economic Herald","url":"https:\/\/economicherald.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","width":850,"height":760,"caption":"Economic Herald"},"image":{"@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=713"}],"version-history":[{"count":0,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/713\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/media\/714"}],"wp:attachment":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}